Learn more about whether Recursion Pharmaceuticals, Inc. or Syndax Pharmaceuticals, Inc. is a better investment based on AAII ...

CBSE Supplementary Exam 2026: Compartment third chance, that is, students who appeared in the 2025 board examination can ...

CBSE has begun the registration process for the Class 12 Supplementary Examination 2026, directing affiliated schools to ...

The Council for the Indian School Certificate Examinations (CISCE) has released the ISC Computer Science (Subject Code - 868) for the Year 2027 evaluation cycle. It is designed specifically to make ...

As the nation marks its 250 anniversary, the Smithsonian invites educators to imagine the future we want to build. High ...

Multiple milestones achieved or on track across wholly owned and partnered programs REC-1245 (RBM39 degrader): Early clinical data in solid tumors demonstrate a well-tolerated safety profile and ...

Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.

"For 2026, we are maintaining our cash operating expense guidance of less than $390 million." (CFO & President of Recursion UK Taylor). "We expect multiple clinical readouts over the next 12 to 18 ...

Earnings call Recursion Pharmaceuticals delivered strong operational progress with a 30% YoY reduction in operating expenses and an extended cash runway into early 2028. Clinical momentum was ...

A total of 28 companies joined The Crunchbase Unicorn Board in April, Crunchbase data shows, with robotics startups and frontier labs leading by number of entrants for the second consecutive month.

Abstract: This article is concerned with the distributed recursive filtering problem for a class of nonlinear time-varying systems over sensor networks (SNs) under state saturations via a ...